12:32 pm Bristol-Myers presents Phase 2b data for novel, investigational attachment inhibitor for HIV-1 infected treatment-experienced patients
View todays social media effects on BMY
View the latest stocks trending across Twitter. Click to view dashboard
See who Bristol is hiring next, click here to view
